Hadassah

Hadassah's Bone Marrow Transplantation Department Receives Prestigious Recognition

Friday, Jun 5 2015

Stem Cell Laboratory at Hadassah Medical Organization

In recognition of its quality performance in harvesting stem cells from live donors and performing bone marrow transplants, the Hadassah Medical Organization's Department of Bone Marrow Transplantation and Cancer Immunotherapy has received the honor of accreditation from the prestigious Joint Accreditation Committee (JACIE) of the International Society for Cellular Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT).

"This prestigious recognition creates tremendous opportunities for joint research and collaboration with leading departments worldwide," said Prof. Reuven Or, the Department's director. "The rigorous process of receiving JACIE's recognition was extremely demanding," he said. "We understood that JACIE's recognition would formally line up our department's amazing work alongside other leading bone marrow departments across the globe. Therefore, we created a quality assurance team within our department to assure that all of the JACIE's standards and criteria were met to the highest degree."

JACIE, jointly established by the ISCT and ESBMT, aims to promote "high-quality patient care and laboratory performance in stem cell collection, processing, and transplantation centers through the development of global standards and an internationally recognized system of accreditation."

Comments

From: nadine on June 28, 2015
what treatment would you suggest for POLYCYTHEMIA VERA ? Thank you,
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Gazan Boy Walks for First Time at Hadassah

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More